← Back to headlines
Xencor Stock Rises After Securing ESMO 2026 Oral Presentation Slot
Biopharmaceutical company Xencor saw its stock increase by 17% after announcing it has secured an oral presentation slot at the European Society for Medical Oncology (ESMO) 2026 conference.
17 Jul, 20:50 — 17 Jul, 20:50
Sources
Showing 1 of 1 sources
